Patricia Font

1.8k total citations
32 papers, 297 citations indexed

About

Patricia Font is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Patricia Font has authored 32 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 13 papers in Genetics and 6 papers in Oncology. Recurrent topics in Patricia Font's work include Acute Myeloid Leukemia Research (21 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Patricia Font is often cited by papers focused on Acute Myeloid Leukemia Research (21 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Patricia Font collaborates with scholars based in Spain, United States and Germany. Patricia Font's co-authors include Celina Benavente, Pilar Ricard, Luis García‐Alonso, Ana Villegas, Javier Loscertales, Santiago Gil, Carlos Soto, José L. Díez‐Martín, Pascual Balsalobre and Mónica Ballesteros and has published in prestigious journals such as Journal of Clinical Oncology, Blood and World Journal of Surgery.

In The Last Decade

Patricia Font

30 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patricia Font Spain	10	199	99	62	53	49	32	297
Mary‐Elizabeth M. Percival United States	10	248 1.2×	71 0.7×	94 1.5×	107 2.0×	45 0.9×	53	356
Rabin Niroula United States	6	120 0.6×	44 0.4×	119 1.9×	58 1.1×	13 0.3×	23	284
Guldeep Uppal United States	10	64 0.3×	43 0.4×	78 1.3×	49 0.9×	9 0.2×	34	269
Audrey Bidet France	10	175 0.9×	88 0.9×	107 1.7×	33 0.6×	9 0.2×	41	275
Magali Donnard France	9	155 0.8×	169 1.7×	124 2.0×	33 0.6×	9 0.2×	16	341
Audrey Sarry France	12	410 2.1×	118 1.2×	152 2.5×	103 1.9×	39 0.8×	27	514
C. Rosé France	10	94 0.5×	80 0.8×	29 0.5×	25 0.5×	5 0.1×	22	271
Marta Sonia González Spain	11	116 0.6×	61 0.6×	124 2.0×	62 1.2×	4 0.1×	38	280
Mariam Thomas Canada	10	68 0.3×	41 0.4×	91 1.5×	48 0.9×	16 0.3×	22	281
Jason Sotzen United States	7	162 0.8×	44 0.4×	209 3.4×	30 0.6×	8 0.2×	9	350

Countries citing papers authored by Patricia Font

Since Specialization

Citations

This map shows the geographic impact of Patricia Font's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Font with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Font more than expected).

Fields of papers citing papers by Patricia Font

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Font. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Font. The network helps show where Patricia Font may publish in the future.

Co-authorship network of co-authors of Patricia Font

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Font. A scholar is included among the top collaborators of Patricia Font based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Font. Patricia Font is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gómez‐Centurión, Ignacio, M. C. Garcı́a, Eva González-Haba, et al.. (2021). Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility. International Journal of Hematology. 115(1). 61–68. 12 indexed citations

Gómez‐Centurión, Ignacio, Gabriela Rodríguez‐Macías, Carolina Martínez‐Laperche, et al.. (2021). Patients with Acute Myeloid Leukemia on Non-Intensive Therapy: Applicability of the European Leukemia Net Risk Classification. Blood. 138(Supplement 1). 3382–3382. 1 indexed citations

Montesinos, Pau, Patricia Font, Adolfo de la Fuente, et al.. (2021). Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain. ClinicoEconomics and Outcomes Research. Volume 13. 263–277. 5 indexed citations

Santini, Valeria, Pierre Fenaux, Koen Van Eygen, et al.. (2021). On-Target Activity of Imetelstat Correlates with Clinical Benefits, Including Overall Survival (OS), in Heavily Transfused Non-Del(5q) Lower Risk MDS (LR-MDS) Relapsed/Refractory (R/R) to Erythropoiesis Stimulating Agents (ESAs). Blood. 138(Supplement 1). 2598–2598. 4 indexed citations

Pérez‐Corral, Ana, Ignacio Gómez‐Centurión, Gabriela Rodríguez‐Macías, et al.. (2021). Day 14 Measurable Residual Disease As a Predictor of Post-Induction Response in Patients with Acute Myeloid Leukemia. Blood. 138(Supplement 1). 1287–1287. 1 indexed citations

Carbonell, Diego, Sergio Lois, Gabriela Rodríguez‐Macías, et al.. (2021). Next Generation Cytogenetics in Myeloid Hematological Neoplasms: Detection of CNVs and Translocations. Cancers. 13(12). 3001–3001. 3 indexed citations

Rodríguez‐Macías, Gabriela, Nieves Dorado, Sonia Osorio, et al.. (2021). Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition. Molecular Oncology. 15(9). 2273–2284. 4 indexed citations

Watts, Justin M., Lionel Adès, Atanas Radinoff, et al.. (2020). MDS-336: Phase 2 Study of Pevonedistat + Azacitidine versus Azacitidine in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)/Chronic Myelomonocytic Leukemia (CMML) or Low-Blast Acute Myelogenous Leukemia (LB-AML) (NCT02610777): Subset Analysis in Higher-Risk MDS. Clinical Lymphoma Myeloma & Leukemia. 20. S323–S324. 1 indexed citations

Platzbecker, Uwe, David P. Steensma, Koen Van Eygen, et al.. (2019). Imerge: A Study to Evaluate Imetelstat (GRN163L) in Transfusion-Dependent Subjects with IPSS Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) That Is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment. Blood. 134(Supplement_1). 4248–4248. 5 indexed citations

10.

Carbonell, Diego, Juan Carlos Triviño, Gabriela Rodríguez‐Macías, et al.. (2019). Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms. Cancers. 11(9). 1364–1364. 22 indexed citations

11.

Ramos, Fernando, Carme Pedro, Mar Tormo, et al.. (2016). Impact of anaemia on health-related quality of life and cardiac remodelling in patients with lower risk myelodysplastic syndromes. Results of GlobQoL study. European Journal of Cancer Care. 26(6). e12426–e12426. 2 indexed citations

12.

Font, Patricia, Javier Loscertales, Carlos Soto, et al.. (2014). Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts. Annals of Hematology. 94(4). 565–573. 50 indexed citations

13.

Font, Patricia, Javier Loscertales, Celina Benavente, et al.. (2012). Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification. Annals of Hematology. 92(1). 19–24. 49 indexed citations

14.

Rosso, Edoardo, et al.. (2012). Double Omental Flap Reduced Perianastomotic Collections and Relaparotomy Rates after Pancreaticoduodenectomy with Pancreaticogastrostomy. World Journal of Surgery. 36(7). 1672–1678. 14 indexed citations

15.

Font, Patricia. (2011). Azacitidine for the treatment of patients with acute myeloid leukemia with 20%–30% blasts and multilineage dysplasia. Advances in Therapy. 28(S3). 1–9. 6 indexed citations

16.

Font, Patricia, et al.. (2011). Acute myeloblastic leukemia. Advances in Therapy. 28(S3). 10–16. 2 indexed citations

17.

Subirá, Dolores, Patricia Font, Lucı́a Villalón, et al.. (2008). Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?. Translational research. 151(5). 240–245. 18 indexed citations

18.

Subirá, Dolores, Patricia Font, Lucı́a Villalón, et al.. (2007). Immunophenotype in Chronic Myelomonocytic Leukemia: Is It Closer to Myelodysplastic Syndromes or to Myeloproliferative Disorders?.. Blood. 110(11). 4621–4621. 1 indexed citations

19.

Font, Patricia, Dolores Subirá, Susana Castañón, et al.. (2006). Evaluation of CD7 and terminal deoxynucleotidyl transferase (TdT) expression in CD34+ myeloblasts from patients with myelodysplastic syndrome. Leukemia Research. 30(8). 957–963. 13 indexed citations

20.

Granados, Enrique, Pilar Llamas, Inmaculada Pinilla, et al.. (1998). Persistent polyclonal B lymphocytosis with multiple bcl-2/IgH rearrangements: a benign disorder.. PubMed. 83(4). 369–75. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact